Skin | Page 59 of 109 | SpiritIndia.com

Health :: Abbott to Expand Presence in Lipid Management Market with Acquisition of Kos Pharmaceuticals

Abbott and Kos Pharmaceuticals, Inc. today announced a definitive agreement for Abbott to acquire Kos for $78 per share in cash, for a total transaction value of $3.7 billion, net of cash currently held by Kos. Based in Cranbury, N.J., Kos is a specialty pharmaceutical company that develops and markets proprietary medications for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company has a growing presence in the $20 billion lipid management market.

Rheumatoid Arthritis :: ORENCIA, abatacept demonstrate continued efficacy in adults with rheumatoid arthritis

Bristol-Myers Squibb Company (NYSE: BMY) today announced that two-year data from three Phase III pivotal trials demonstrate the long-term efficacy of ORENCIA? (abatacept) in adult patients with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs) such as methotrexate and TNF antagonists. The data also demonstrate that ORENCIA provided clinically meaningful improvements in multiple aspects of health-related quality of life and physical function, sustained improvements in pain and had a consistent safety and tolerability profile through two years of treatment. These data will be presented at the upcoming 2006 American College of Rheumatology (ACR) Annual Scientific Meeting.

Cancer :: Patients respond well to first study to test higher doses of an anti-cancer drug

Researchers in the UK and the United States have found that a drug composed of an antibody carrying a highly toxic anti-cancer agent is well tolerated by patients at much higher doses than have been used before, according to research presented at the 18th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Prague on Friday.

Cancer :: Firefighters face increased risk for certain cancers

University of Cincinnati (UC) environmental health researchers have determined that firefighters are significantly more likely to develop four different types of cancer than workers in other fields. Their findings suggest that the protective equipment firefighters have used in the past didn’t do a good job in protecting them against cancer-causing agents they encounter in their profession, the researchers say.

Genome :: Decoded sea urchin genome shows surprising relationship to man

The Sea Urchin Genome Sequencing Project (SUGSP) Consortium, led by the Human Genome Sequencing Center at Baylor College of Medicine (BCM-HGSC) in Houston, announced today the decoding and analysis of the genome sequence of the sea urchin, Strongylocentrotus purpuratus.

Flu :: With BYU partner, FSU’s Magnet Lab researchers deciphering flu virus

As the Northern Hemisphere braces for another flu season, researchers at Florida State University’s National High Magnetic Field Laboratory in Tallahassee, Florida are making strides toward better understanding the mechanics of the virus that causes it — a virus that kills between one-quarter and one-half million people each year.

Genome :: Decoded sea urchin genome shows surprising relationship to humans – Houston

The Sea Urchin Genome Sequencing Project consortium, led by the Human Genome Sequencing Center at Baylor College of Medicine in Houston, announced today the decoding and analysis of the genome sequence of the sea urchin, Strongylocentrotus purpuratus.

Melanoma :: Scientists harness diptheria toxin and interleukin 2 to help the immune system attack melanoma

Researchers investigating ways of prompting the immune system to recognise and kill tumour cells have found that a drug containing parts of the diptheria toxin appears to work well in patients with advanced melanoma, according to research presented at the 18th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics on Thursday.

Smoking :: Govt to continue fight against tobacco cos: Ramadoss

Accusing Multinational tobacco companies of dumping their products in India and trying to “entice” youngsters to take up smoking, Union Health Minister Anbumani Ramadoss today said the government would continue to fight the companies tooth and nail.

Psychology :: Social exclusion changes brain function and can lead to poor decision-making

In new research, reported in the current online issue of the journal Social Neuroscience, researchers from the University of Georgia and San Diego State University report for the first time that social exclusion actually causes changes in a person’s brain function and can lead to poor decision-making and a diminished learning ability.